As the pan-European STOXX Europe 600 Index experiences modest gains amid hopes for quicker interest rate cuts by the European Central Bank, Sweden's market landscape remains a focal point for investors seeking growth opportunities. In this context, Swedish growth companies with high insider ownership are particularly appealing, as they often indicate strong confidence from those closest to the business and can offer resilience in fluctuating economic conditions.
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Truecaller (OM:TRUE B) | 29.7% | 21.7% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Biovica International (OM:BIOVIC B) | 18.3% | 78.5% |
BioArctic (OM:BIOA B) | 34% | 98.4% |
Yubico (OM:YUBICO) | 37.5% | 42.2% |
KebNi (OM:KEBNI B) | 36.3% | 86.1% |
InCoax Networks (OM:INCOAX) | 20.1% | 115.5% |
C-Rad (OM:CRAD B) | 16.1% | 33.9% |
OrganoClick (OM:ORGC) | 23.1% | 109.0% |
Let's explore several standout options from the results in the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: EQT AB (publ) is a global private equity firm focused on private capital and real asset segments, with a market cap of approximately SEK392.56 billion.
Operations: The company generates revenue through its segments, with €1.28 billion from Private Capital, €878.70 million from Real Assets, and €37.20 million from Central operations.
Insider Ownership: 12.3%
Revenue Growth Forecast: 15.7% p.a.
EQT AB showcases a strong growth trajectory with earnings forecasted to grow significantly at 33.7% annually, outpacing the Swedish market. Despite substantial insider selling in recent months, the company maintains high insider ownership which can align management interests with shareholders. Recent strategic moves include exploring acquisitions and divestitures, such as vying for Singapore Post's Australian assets and considering a sale of Banking Circle, indicating active portfolio management aimed at enhancing value creation.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Swedencare AB (publ) develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses across Sweden, the United Kingdom, Europe, North America, Asia, and internationally with a market cap of SEK6.39 billion.
Operations: The company's revenue segments include SEK383.90 million from Europe, SEK591.10 million from Production, and SEK1.70 billion from North America.
Insider Ownership: 12.2%
Revenue Growth Forecast: 11.1% p.a.
Swedencare demonstrates robust growth potential with earnings forecasted to grow significantly at 55.7% annually, surpassing the Swedish market's growth rate. Recent financial results show improved profitability, with net income rising to SEK 51 million for the first half of 2024. The company has seen substantial insider buying in recent months, indicating confidence in its future prospects. However, revenue growth is expected to be moderate at 11.1% annually, below the high-growth threshold of 20%.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Swedish Logistic Property AB is a real estate company focused on acquiring, developing, and managing logistics properties in Sweden, with a market cap of SEK9.95 billion.
Operations: Swedish Logistic Property AB generates its revenue from acquiring, developing, and managing logistics properties within Sweden.
Insider Ownership: 11.3%
Revenue Growth Forecast: 19.5% p.a.
Swedish Logistic Property exhibits solid growth potential, with earnings forecasted to grow significantly at 28% annually, outpacing the Swedish market. Despite a recent dip in quarterly net income to SEK 70 million, nine-month results show improved profitability at SEK 397 million. The company trades at a favorable price-to-earnings ratio of 23.5x compared to industry peers and has expanded its portfolio by acquiring logistics properties valued at SEK 128.3 million through a share-financed transaction.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com